Q4 2025 Earnings Call February 13, 2026 2:00 PM ESTCompany ParticipantsLukas Hartwich - Executive Vice President ...
Developed in partnership with the Royal College of Physicians, the Society for Acute Medicine and the British Geriatrics Society.
The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and ...
Calls for a new Minister for Social Cohesion reflect anxiety about Australia’s civic health, but risk mistaking rhetorical ...
When it comes to physical design and comfort, both planar headphones feel well-constructed, but they differ in how they approach wearability over extended listening sessions. The Fiio JT7 catches your ...
Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.
Key market opportunities include the growing demand for point-of-care imaging and AI-guided applications, expanding in emergency, primary, and home settings. Strong growth in Asia-Pacific and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results